Showing 201-210 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model Northwestern University Jacqueline Burke Cures 01-July-2023 to 30-June-2026 $998.275,64
Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes University of Pittsburgh Alok Joglekar Cures 01-March-2023 to 28-February-2026 $900.000,00
MRI of Pancreas Perfusion in Response to Glucose University of Texas at Austin Jack Virostko Cures 01-July-2023 to 30-June-2025 $187.620,00
Exploiting CRISPR Strategy to Modify T-Cell Lipid Signaling and Mitigate T1D Development The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-May-2023 to 30-April-2025 $199.989,05
Cellular Sentinels of Islet Transplant Rejection California Institute of Technology Mikhail Shapiro Cures 01-July-2023 to 30-June-2026 $750.000,00
Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts The Regents of the University of California, Los Angeles Oluwatayo Ikotun Cures 01-February-2024 to 31-January-2027 $749.996,25
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-May-2023 to 30-April-2026 $749.763,00
IL-37-EXPRESSING TREG CELLS TO IMPROVE T1D THERAPEUTIC STRATEGY Regents of the University of Colorado Mayumi Fujita Cures 01-March-2023 to 28-February-2026 $750.000,00
A Novel Magnetorheological Insulin Pump Georgia Southern University Research and Service Foundation, Inc Sevki Cesmeci Improving Lives 01-June-2023 to 31-May-2026 $199.516,50
Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell Colorado School of Mines Nikki Farnsworth Cures 01-April-2023 to 31-March-2026 $900.000,00